Open AccessA left atrial appendage thrombus that developed during prophylactic low‐dose dabigatran treatment resolved after switching to apixaban
Author(s) -
Koyama Taku,
Otsuka Yoritaka,
Kawahara Masaaki,
Imoto Yuki,
Nakamura Keita,
Kodama Sunao,
Noguchi Hiroo
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.933
Subject(s) - apixaban , medicine , dabigatran , thrombus , atrial fibrillation , intracardiac injection , cardiology , thrombolysis , warfarin , rivaroxaban , myocardial infarction
Key Clinical Message We describe a case of atrial fibrillation in which an intracardiac thrombus that could not be prevented with “low‐dose” dabigatran treatment was resolved by switching to apixaban treatment. Thrombolysis using direct oral anticoagulants ( DOAC s) could be a therapeutic option for patients with intracardiac thrombi, although the efficacies of different DOAC s seem to differ and need further examination.